Maher A. Kamel
Impact in
- Pharmacology top 2%
- Drug-Induced Hepatotoxicity and Protection
- Ginger and Zingiberaceae research
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
Papers in
- Physiology 27
- Adipose Tissue and Metabolism 17
-
- Metabolism, Diabetes, and Cancer 6
- Co-authors
- Mokhtar I. Yousef (12 shared papers)Mohamed I. Saad (11 shared papers)Mennatallah A. Ali (8 shared papers)A.S. El-Sharaky (4 shared papers)Al‐Sayeda A. Newairy (3 shared papers)Saber M. Eweda (2 shared papers)Mennatallah A. Gowayed (9 shared papers)Ibrahim El Tantawy El Sayed (4 shared papers)
- Journals
- Scientific Reports (5 papers)European Journal of Pharmacology (4 papers)International Journal of Molecular Sciences (3 papers)Molecular and Cellular Biochemistry (3 papers)International Journal of Pharmaceutics (3 papers)
- Partner nations
- EgyptSaudi ArabiaJordan
In The Last Decade
Maher A. Kamel
99 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 121
- Pharmacology 167
- Molecular Medicine 71
- Biochemistry 73
- Complementary and alternative medicine 97
- Pharmaceutical Science 68
Countries citing papers authored by Maher A. Kamel
This map shows the geographic impact of Maher A. Kamel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maher A. Kamel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maher A. Kamel more than expected).
Fields of papers citing papers by Maher A. Kamel
This network shows the impact of papers produced by Maher A. Kamel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maher A. Kamel. The network helps show where Maher A. Kamel may publish in the future.
Co-authors
The 25 scholars most cited alongside Maher A. Kamel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 104 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 113 | |
| 2 | 2009 | 105 | |
| 3 | 2015 | 52 | |
| 4 | 2015 | 48 | |
| 5 | 2023 | 44 | |
| 6 | 2015 | 43 | |
| 7 | 2020 | 43 | |
| 8 | 2021 | 36 | |
| 9 | 2015 | 35 | |
| 10 | 2022 | 34 | |
| 11 | 2022 | 33 | |
| 12 | 2015 | 33 | |
| 13 | 2018 | 33 | |
| 14 | 2018 | 31 | |
| 15 | 2021 | 31 | |
| 16 | 2020 | 31 | |
| 17 | 2008 | 30 | |
| 18 | 2023 | 29 | |
| 19 | 2019 | 29 | |
| 20 | 2019 | 29 |
About Maher A. Kamel
Maher A. Kamel is a scholar working on Physiology, Molecular Biology, Epidemiology, Pediatrics, Perinatology and Child Health and Obstetrics and Gynecology, having authored 104 papers that have together received 1.5k indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (17 papers), Birth, Development, and Health (14 papers), Gestational Diabetes Research and Management (11 papers), Nanoparticles: synthesis and applications (9 papers), Liver Disease Diagnosis and Treatment (8 papers), Pregnancy and preeclampsia studies (8 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). The work is most often cited by research in Pharmacology (167 citations), Molecular Medicine (71 citations), Biochemistry (73 citations), Complementary and alternative medicine (97 citations) and Pharmaceutical Science (68 citations). Maher A. Kamel has collaborated with scholars based in Egypt, Saudi Arabia and Jordan. Frequent co-authors include Mokhtar I. Yousef, Mohamed I. Saad, Mennatallah A. Ali, A.S. El-Sharaky, Al‐Sayeda A. Newairy, Saber M. Eweda, Mennatallah A. Gowayed, Ibrahim El Tantawy El Sayed, Mona Shehata and Ahmed S. Attia. Their work appears in journals such as Scientific Reports, European Journal of Pharmacology, International Journal of Molecular Sciences, Molecular and Cellular Biochemistry and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.